🔗 Permalink

Inventor profile of:

Arthur Driscoll

City:

Reading, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2026-02-26

Top Assignees for applications by Arthur Driscoll

The entities that hold a legal rights for patent applications filed by inventor Driscoll Arthur:

OCULAR THERAPEUTIX, INC. 5 Bedford, MA United States
Covidien LP 4 Mansfield, MA United States
Confluent Surgical, Inc. 4 Waltham, MA United States
CONFLUENT SURGICAL, INC. 3 Bedford, MA United States
INCEPT, LLC 2 Lexington, MA United States
Confluent Surgical, Inc. 1 Mansfield, MA United States

Recent patent applications by Driscoll Arthur

Arthur Driscoll from Reading, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-26

US20260053735A1

Human necessities

OCULAR HYDROGEL TYROSINE KINASE INHIBITOR IMPLANTS

#2 | 2025-10-30

US20250332094A1

Human necessities

OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR

#3 | 2025-08-28

US20250268818A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES

#4 | 2025-08-14

US20250256007A1

Human necessities

GELMA POLYMER COMPOSITIONS COMPRISING CELLS

#5 | 2025-05-08

US20250144012A1

Human necessities

INTRACAMERAL DRUG DELIVERY DEPOTS

#6 | 2024-08-29

US20240285518A1

Human necessities

OCULAR HYDROGEL TYROSINE KINASE INHIBITOR IMPLANTS

#7 | 2024-05-23

US20240165018A1

Human necessities

HYDROGEL IMPLANTS FOR LOWERING INTRAOCULAR PRESSURE

#8 | 2023-12-07

US20230390189A1

Human necessities

OCULAR IMPLANT CONTAINING AN ACTIVE INGREDIENT

#9 | 2023-09-14

US20230285282A1

Human necessities

OCULAR IMPLANT CONTAINING AN ACTIVE INGREDIENT

#10 | 2023-09-14

US20230285281A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES

#11 | 2023-04-20

US20230118774A1

Human necessities

OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR

#12 | 2023-02-09

US20230040637A1

Human necessities

OCULAR HYDROGEL TYROSINE KINASE INHIBITOR IMPLANTS

#13 | 2022-12-22

US20220401356A1

Human necessities

INTRACAMERAL DRUG DELIVERY DEPOTS

#14 | 2022-11-03

US20220347094A1

Human necessities

Methods of treatment with an ocular implant containing a tyrosine kinase inhibitor

#15 | 2022-07-14

US20220218643A1

Human necessities

Methods of treating ocular diseases using polyalkylene glycol intracameral implants with polyactide travoprost particles

#16 | 2022-03-17

US20220079876A1

Human necessities

OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR

#17 | 2021-10-07

US20210308043A1

Human necessities

Ocular implant containing a tyrosine kinase inhibitor

#18 | 2021-08-19

US20210251893A1

Human necessities

Compositions and Methods for Treating Ocular Diseases

#19 | 2021-03-18

US20210077299A1

Human necessities

COATED IMPLANTS

#20 | 2020-10-29

US20200337990A1

Human necessities

HYDROGEL IMPLANTS FOR LOWERING INTRAOCULAR PRESSURE

#21 | 2020-10-29

US20200337989A1

Human necessities

OCULAR HYDROGEL TYROSINE KINASE INHIBITOR IMPLANTS

#22 | 2018-03-29

US20180085307A1

Human necessities

Intracameral drug delivery depots

#23 | 2017-01-26

US20170020729A1

Human necessities

Coated implants

#24 | 2013-08-29

US20130225857A1

Chemistry; metallurgy

Crosslinked polymers with the crosslinker as therapeutic for sustained release

#25 | 2012-08-02

US20120197028A1

Chemistry; metallurgy

Crosslinked polymers with the crosslinker as therapeutic for sustained release

#26 | 2012-07-12

US20120175810A1

Human necessities

Systems and method for forming a coaxial implant

#27 | 2012-02-23

US20120043399A1

Performing operations; transporting

Silicone spray tip

#28 | 2010-09-30

US20100249829A1

Human necessities

Compartmented syringe

#29 | 2009-10-29

US20090266918A1

Performing operations; transporting

Silicone spray tip

InventorID:

417042 ⎘